Sakara Digital https://validator.w3.org/feed/docs/rss2.html Sakara Signals | August 1, 2025 Where Are You in The AI Maturity Model? Inspection Readiness Is a Mindset What is a Digital Adoption Solution Computer System Validation What if every user could perform at full capacity the moment they log in? Establishing an AI Policy: A Comprehensive White Paper for Life Sciences Teams Team Extension Strategic Partnerships What We Do Our Team Success Stories Our Engagement Approach Our Collection: By Series Operational Excellence Workshops Core Values Let’s Connect About Us Launchpoint AI Roadmap℠ Industries We Serve Data Quality & Integrity Services Manufacturing & Quality Operations GxP Records Retention and Archiving: Designing for 30 Years Nitrosamine Risk Assessment Data Management Data Catalog Selection for Life Sciences: Beyond the Feature Grid ICH Q9(R1) Implementation: Turning Quality Risk Management Into Practice The Purolea Letter: What Pharma’s First AI Warning Means for GxP Compliance OEE and Line Performance Analytics in Pharma Packaging Analytics Engineering in Regulated Environments: dbt, Version Control, and Validation Tech Transfer to a CDMO: The Digital Playbook EMA Reopens the GenAI Question in Annex 22: Reading the June 2026 Expert Workshop The EU AI Act Deadline That Moved: High-Risk Rules Now Land in December 2027 EU AI Act Article 10: What the Training Data Requirements Mean for Pharma Data Teams Bias Testing in Pharma AI: Beyond the Demographics Checklist The Fractional CTO Engagement Roadmap for Biotech Clinical Trial Diversity Action Plans: The Data and Systems Behind the Commitment Why AI Fails in Pharma: The Real Reason Isn’t the Technology The Velocity of Lasting Change, Part 2 – The Cost of Compliance A Framework for AI Success: Framing, Structure, and Evaluation Understanding AI Maturity: Part 4 – Stage 3: Programmatic Use Black Mesa GAIP Progress Report: What Is Public So Far and What It Signals GAIP for ADME-Tox: What the ARPA-H CATALYST Work Means for Nonclinical Data Integrity MHRA on Using AI to Draft GxP Inspection Responses: The New Standard eCOA and ePRO Platform Selection: A Scoring Framework Vendor Risk Management for AI-Enabled Pharma Services Batch Genealogy for Biologics: Tracing a Lot Back Through Bulk and Cell Bank Data Historian Modernization on the Pharma Shop Floor Clinical Supply Forecasting and IRT: Reducing Overage Without Risking Stockouts Direct Data Capture vs EDC: What Changes for Clinical Data Management Context Graphs for Regulatory Decision Traceability: Why Pharma Needs This Now